Oppenheimer analyst Kristen Owen maintained a Buy rating on Bioceres Crop Solutions (BIOX – Research Report) today and set a price target of $13.00. The company’s shares closed yesterday at $6.66.
Oppenheimer began coverage of Nutanix (NASDAQ:NTNX) with an Outperform rating and an $80 price target. Analyst Param Singh noted that their bullish stance is based on their view that Nutanix — is a ...